GMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemic
Update – MRA GMP Clearances expiring between December 2022 and December 2023
Information about the TGA's approach to Good Manufacturing Practice (GMP) inspections and clearances for overseas manufacturers of medicines and biologicals during the COVID-19 pandemic.
Published
Related content
- TGA suspends overseas GMP inspections and QMS audits until further noticeDue to changes in travel restrictions, all overseas GMP inspections and QMS audits have now been suspended until further notice
- GMP Clearance: Extension processing timesDelays in processing timeframes of applications to extend GMP Clearances.
- Domestic Good Manufacturing Practice (GMP) inspections during the COVID-19 pandemicConducting domestic inspections during the Coronavirus (COVID-19) pandemic